Morgan Stanley Relay Therapeutics, Inc. Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,764,096 shares of RLAY stock, worth $11.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,764,096

Previous 1,422,346 24.03%

Holding current value

$11.7 Million

Previous $4.92 Million 87.12%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$3.22 - $5.22 $1.1 Million - $1.78 Million	341,750 Added 24.03%	1,764,096 $9.21 Million
Q2 2025 Aug 15, 2025	SELL	$2.0 - $3.49 $341,680 - $596,231	-170,840 Reduced 10.72%	1,422,346 $4.92 Million
Q1 2025 May 15, 2025	BUY	$2.62 - $4.92 $766,129 - $1.44 Million	292,416 Added 22.48%	1,593,186 $4.17 Million
Q4 2024 Feb 14, 2025	BUY	$4.12 - $6.8 $1.4 Million - $2.3 Million	338,659 Added 35.2%	1,300,770 $5.36 Million
Q3 2024 May 14, 2025	SELL	$6.23 - $9.51 $1.75 Million - $2.66 Million	-280,167 Reduced 22.55%	962,111 $6.81 Million

Q3 2024 Nov 14, 2024	SELL	$6.23 - $9.51 $1.75 Million - $2.66 Million	-280,167 Reduced 22.55%	962,111 $6.81 Million
Q2 2024 May 14, 2025	SELL	$5.9 - $8.02 $345,102 - $469,105	-58,492 Reduced 4.5%	1,242,278 $8.1 Million
Q2 2024 Oct 17, 2024	BUY	$5.9 - $8.02 $503,016 - $683,761	85,257 Added 7.37%	1,242,278 $8.1 Million
Q2 2024 Aug 14, 2024	BUY	$5.9 - $8.02 $503,016 - $683,761	85,257 Added 7.37%	1,242,278 $8.1 Million
Q1 2024 Oct 17, 2024	SELL	$7.5 - $12.07 $639,427 - $1.03 Million	-85,257 Reduced 6.86%	1,157,021 $9.6 Million
Q1 2024 Aug 16, 2024	BUY	$7.5 - $12.07 $3.21 Million - $5.17 Million	428,317 Added 58.78%	1,157,021 $9.6 Million
Q1 2024 May 15, 2024	BUY	$7.5 - $12.07 $3.21 Million - $5.17 Million	428,317 Added 58.78%	1,157,021 $9.6 Million
Q4 2023 Aug 16, 2024	SELL	$6.01 - $11.48 $3.09 Million - $5.9 Million	-513,574 Reduced 41.34%	728,704 $8.02 Million
Q4 2023 Feb 13, 2024	BUY	$6.01 - $11.48 $427,689 - $816,951	71,163 Added 10.82%	728,704 $8.02 Million
Q3 2023 Nov 15, 2023	SELL	$8.24 - $12.97 $988,190 - $1.56 Million	-119,926 Reduced 15.43%	657,541 $5.53 Million
Q2 2023 Aug 14, 2023	BUY	$9.99 - $18.27 $2.15 Million - $3.93 Million	215,333 Added 38.31%	777,467 $9.76 Million
Q1 2023 May 15, 2023	SELL	$15.0 - $22.76 $27.1 Million - $41.1 Million	-1,807,210 Reduced 76.27%	562,134 $9.26 Million
Q4 2022 Feb 14, 2023	BUY	$14.16 - $24.02 $28.7 Million - $48.7 Million	2,027,003 Added 592.1%	2,369,344 $35.4 Million
Q3 2022 Nov 14, 2022	SELL	$18.07 - $31.37 $5.13 Million - $8.9 Million	-283,783 Reduced 45.32%	342,341 $7.66 Million
Q2 2022 Oct 27, 2022	BUY	$13.31 - $34.88 $2.59 Million - $6.79 Million	194,644 Added 45.11%	626,124 $10.5 Million
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $2.59 Million - $6.79 Million	194,644 Added 45.11%	626,124 $10.5 Million
Q1 2022 Oct 27, 2022	SELL	$20.26 - $32.36 $3.94 Million - $6.3 Million	-194,644 Reduced 31.09%	431,480 $12.9 Million
Q1 2022 May 13, 2022	SELL	$20.26 - $32.36 $1.86 Million - $2.98 Million	-92,013 Reduced 17.58%	431,480 $12.9 Million
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $1.99 Million - $2.84 Million	76,702 Added 17.17%	523,493 $16.1 Million
Q3 2021 Nov 15, 2021	BUY	$29.75 - $37.99 $13.3 Million - $17 Million	446,791 New	446,791 $14.1 Million

Others Institutions Holding RLAY

# of Institutions

216

Shares Held

168M

Call Options Held

714K

Put Options Held

14.9K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $796M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account